Clinical radiology最新文献_第4页

Ultrasound-based ADNEX model for differentiating between benign, borderline, and malignant epithelial ovarian tumours 基于超声的ADNEX模型鉴别良性、交界性和恶性卵巢上皮肿瘤。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.106761

W. Xie , Q. Zhang , Y. Wang , Z. Xiang , P. Zeng , R. Huo , Z. Du , L. Tang

{"title":"Ultrasound-based ADNEX model for differentiating between benign, borderline, and malignant epithelial ovarian tumours","authors":"W. Xie , Q. Zhang , Y. Wang , Z. Xiang , P. Zeng , R. Huo , Z. Du , L. Tang","doi":"10.1016/j.crad.2024.106761","DOIUrl":"10.1016/j.crad.2024.106761","url":null,"abstract":"<div><h3>Background</h3><div>The purpose of this study was to evaluate the ability of the International Ovarian Tumor Analysis-Assessment of Different NEoplasias in the adneXa (IOTA-ADNEX) model to distinguish among benign, borderline, and malignant epithelial ovarian tumours (BeEOTs, BEOTs, and MEOTs, respectively).</div></div><div><h3>Methods</h3><div>The study included 813 patients with BeEOTs, BEOTs, and MEOTs who underwent ultrasound examinations and pelvic operations. Comparisons were made between the clinical information and ultrasonographic features of the three patient groups, and the histopathological diagnosis was the gold standard. The sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve (AUC) of the ADNEX model were calculated.</div></div><div><h3>Results</h3><div>This was a single-centre retrospective study. Of the 813 patients, 257 (31.6%) had BeEOTs, 114 (14.0%) had BEOTs, and 442 (54.4%) had MEOTs. For a cut-off value of 10% to identify the overall risk for ovarian cancer (OC), the sensitivity and specificity were 99.1% and 73.2%, respectively. According to the receiver operating characteristicscurves, the AUC was 0.987 (95% CI: 0.981-0.993) for BeEOTs compared with MEOTs, 0.820 (95% CI: 0.768-0.872) for BeEOTs compared with BEOTs, 0.912 (95% CI: 0.876-0.948) for BeEOTs compared with stage I OC, and 0.995 (95% CI: 0.992-0.998) for BeEOTs compared with stages II-IV OC. The AUC was 0.614 (95% CI: 0.519-0.709) for BEOTs compared with stage I OC, 0.903 (95% CI: 0.869-0.937) for BEOTs compared with stages II-IV OC, and 0.851 (95% CI: 0.800-0.902) for stage I OC compared with stages II-IV OC.</div></div><div><h3>Conclusions</h3><div>The IOTA-ADNEX model demonstrated good diagnostic performance for the three categories of EOTs and may have the potential to be popularised in assisting radiologists in the assessment of adnexal masses in the future.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"81 ","pages":"Article 106761"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142892629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Interventional radiology is growing and is a pillar of modern cost-effective healthcare across the world 介入放射学正在不断发展壮大，是全球具有成本效益的现代医疗保健的支柱。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.09.012

M. Bolger , M.W. Lukies , F. Arfeen , W. Clements

引用次数: 0

The role of microwave ablation in combination with surgery in the management of multiple high-risk pulmonary nodules 微波消融联合手术在治疗多发性高危肺结节中的作用。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.09.013

Y. Chen, J. Li, S. Ma, Z. Zhang, C. Li, F. Kong

{"title":"The role of microwave ablation in combination with surgery in the management of multiple high-risk pulmonary nodules","authors":"Y. Chen, J. Li, S. Ma, Z. Zhang, C. Li, F. Kong","doi":"10.1016/j.crad.2024.09.013","DOIUrl":"10.1016/j.crad.2024.09.013","url":null,"abstract":"<div><h3>AIM</h3><div>To evaluate the feasibility and safety of surgical resection combined with microwave ablation (MWA) for patients with multiple high-risk pulmonary nodules.</div></div><div><h3>MATERIALS AND METHODS</h3><div>From September 2010 to November 2023, a total of 166 early multiple high-risk pulmonary nodule patients in our institution were retrospectively analyzed. Fifty-three patients who underwent surgical resection in combination with MWA were considered as the observation group, and 113 patients who underwent two operations or one operation to remove nodules in two lobes of the lungs were considered as the control group. The primary endpoint was postoperative progression-free survival (PFS). Secondary endpoints were lung function, postoperative complications, and length and cost of hospitalization.</div></div><div><h3>RESULTS</h3><div>In the observation group, the median PFS was 37 months (1–63 months), 9 patients (16.98%) had postoperative recurrence, and the 1-year and 3-year PFS rates were 97.6% and 89.0%, respectively. In the control group, the median PFS was 36 months (1–56 months), 10 patients (8.84%) had postoperative recurrence, and the 1-year and 3-year PFS rates were 99% and 97.8%, respectively. The difference between the two groups was not statistically significant (<em>P</em> = 0.392). Lung function measurements showed a decrease in patients after surgery (<em>P</em><0.05), and no significant change in patients after MWA (<em>P</em> > 0.05). Compared with two surgical resections, the combined treatment required less hospitalization and cost (<em>P</em> < 0.05).</div></div><div><h3>CONCLUSION</h3><div>For patients with multiple high-risk pulmonary nodules, surgical resection in combination with microwave ablation is an effective and safe treatment, which has less hospitalization and cost than using surgical resection alone.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"81 ","pages":"Article 106707"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Computed tomography morphomics and antifibrotic therapy in idiopathic pulmonary fibrosis 特发性肺纤维化的计算机断层形态组学和抗纤维化治疗。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.106759

A.T. O'Mahony , M.G. Waldron , P.J. Henry , S. Shet , P.W. O'Regan , D.M. Bennett , D.J. Ryan , M.M. Maher , M.T. Henry

{"title":"Computed tomography morphomics and antifibrotic therapy in idiopathic pulmonary fibrosis","authors":"A.T. O'Mahony , M.G. Waldron , P.J. Henry , S. Shet , P.W. O'Regan , D.M. Bennett , D.J. Ryan , M.M. Maher , M.T. Henry","doi":"10.1016/j.crad.2024.106759","DOIUrl":"10.1016/j.crad.2024.106759","url":null,"abstract":"<div><h3>AIM</h3><div>Idiopathic pulmonary fibrosis (IPF) is a debilitating and fatal lung disease. Changes in body composition potentially correlate with outcomes in patients with IPF.</div></div><div><h3>MATERIALS AND METHODS</h3><div>Patients with IPF on antifibrotic treatment attending a single institution were identified and retrospectively evaluated (n=84). Three groups were formed based on antifibrotic treatment: pirfenidone group, nintedanib group and pirfenidone-nintedanib switch group. Morphomic analysis of muscle quantity (cross-sectional area in cm<sup>2</sup>) and quality (density in Hounsfield Units) on thoracic computed tomography (CT) was performed using a web-based morphomic segmentation tool. Bilateral erector spinae and pectoralis muscles were measured at pre-defined vertebral levels.</div></div><div><h3>RESULTS</h3><div>All three treatment groups showed a statistically significant decline in forced vital capacity (FVC), diffusion capacity of the lung for carbon monoxide (D<sub>L</sub>CO), pectoral muscle cross sectional area (PMA), and erector spinae muscle cross-sectional area (ESMA). Muscle density did not change significantly. Differences existed in analytic morphomics between treatment groups. Patients with a pretreatment body mass index (BMI) below 30 were found to have a significantly greater loss of PMA when treated with nintedanib instead of pirfenidone. FVC and D<sub>L</sub>CO did not differ between treatment groups.</div></div><div><h3>CONCLUSION</h3><div>There were no direct correlations between pulmonary function and morphomic parameters in our entire group of IPF patients. However, between different treatment groups, the rate of muscle bulk loss differed. This is an important consideration for clinicians when deciding on an antifibrotic agent of choice.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"81 ","pages":"Article 106759"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142876541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

SCOUT® radar reflectors for impalpable lesion localisation in the breast and axilla: our experience in the first 500 patients SCOUT®雷达反射器用于乳房和腋窝不可触摸病变定位：我们在前500名患者中的经验。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.106777

S. Siddiqui , M. Povey , M. Rowland , S. Sharma

{"title":"SCOUT® radar reflectors for impalpable lesion localisation in the breast and axilla: our experience in the first 500 patients","authors":"S. Siddiqui , M. Povey , M. Rowland , S. Sharma","doi":"10.1016/j.crad.2024.106777","DOIUrl":"10.1016/j.crad.2024.106777","url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to detail our experience of using SCOUT® radar reflector for lesion localisation in the breast and axilla.</div></div><div><h3>Materials and methods</h3><div>This is a prospective cohort study describing our clinical experience with the first 500 patients who received SCOUT® to localise lesions in the breast and axilla (from 23 July 2020 to 4 April 2022). Study measures include patient demographics, lesion location, diagnostic pathways (screening or symptomatic), imaging, and surgical and pathology outcomes.</div></div><div><h3>Results</h3><div>Of the 500 patients, most patients (n = 424; 84.8%) had a single device inserted. A total of 361 had SCOUT® inserted under ultrasound guidance, 128 under stereotactic guidance, and 11 under dual mammographic and ultrasonographic guidance. We successfully inserted SCOUT® in 33 patients for lymph node identification for potential targeted axillary dissection. The mean time between SCOUT® insertion and the planned surgical procedure was 40.6 days.</div></div><div><h3>Conclusion</h3><div>Our results suggest that SCOUT® is a promising preoperative localisation device for nonpalpable breast and axillary lesions. Its implementation has the potential to optimise the clinical workflow by eliminating the need for a separate localisation procedure using conventional localisation markers and streamlining the treatment pathway.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"81 ","pages":"Article 106777"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142930751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Imaging appearances of perinephric myxoid pseudotumor of fat (PMPF) 肾周黏液性脂肪假瘤（PMPF）的影像学表现。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.106775

M. Sugi, A. Lombardi, I. Krishnan, K. Sandrasegaran

{"title":"Imaging appearances of perinephric myxoid pseudotumor of fat (PMPF)","authors":"M. Sugi, A. Lombardi, I. Krishnan, K. Sandrasegaran","doi":"10.1016/j.crad.2024.106775","DOIUrl":"10.1016/j.crad.2024.106775","url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to identify the imaging feature of perinephric myxoid pseudotumor of fat (PMPF) in a large cohort.</div></div><div><h3>Materials and Methods</h3><div>Institutional radiology and pathology databases were queried for PMPF for the period from January 2010 to December 2023. Of the 22 identified individuals, two were excluded due to nonavailability of computed tomography (CT) or magnetic resonance (MR) images and five due to lack of pathological confirmation. The study cohort comprised of 15 individuals (males = 10), with median age of 59 years (range: 26–87 years). Three abdominal radiologists in consensus reviewed all relevant CT, magnetic resonance imaging (MRI) and positron emission tomography (PET) images.</div></div><div><h3>Results</h3><div>Seventeen tumuors were analysed since two individuals had bilateral tumuors. The tumuors were at the renal hilum (n=7) or perinephric space (n=10). Two imaging patterns were seen: hazy ill-defined predominantly fatty mass (n=9) or a soft tissue mass (n=8) with variable fat content (0–90%). At presentation, the tumuors ranged in size from 1.5 to 16.5 cm (median: 6.2 cm). The perihilar tumuors encased central renal vessels without occlusion or thrombus. Ureteric encasement and mild hydronephrosis were seen in 11 and 4 tumuors, respectively. Most (9 of 13) of the affected native kidneys and all transplant kidneys (n=5) showed parenchymal poor contrast enhancement. Tumuors with greater than 12-month follow-up (n=11) showed a median growth of 15%.</div></div><div><h3>Conclusion</h3><div>PMPF may be considered in the diagnosis of tumuors with soft tissue and fat components situated at the renal hilum or perinephric space. The delayed contrast enhancement, relative lack of mass effect for size, and poor function of affected kidney are diagnostic features.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"81 ","pages":"Article 106775"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142969862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Imaging of hypoglossal palsy: a pictorial synopsis 舌下麻痹的影像：图像摘要。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.106754

J. Ragittaran , A. Kamalasanan , R.D. White , T. Sudarshan

引用次数: 0

Classifying, recognizing, and troubleshooting errors in magnetic resonance imaging (MRI)-guided breast biopsies 磁共振成像（MRI）引导的乳腺活组织检查中的错误分类、识别和故障排除。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.09.020

B. Tran , A. Mobley , S. Colvin , S. Woodard

引用次数: 0

Centrilobular nodules are predictive chest computed tomography (CT) findings related to adult T-cell leukemia/lymphoma development in human T-lymphotropic virus type I carriers 小叶中心结节是预测人类嗜t淋巴病毒I型携带者成人t细胞白血病/淋巴瘤发展的胸部计算机断层扫描（CT）结果。

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/j.crad.2024.106765

H. Sato , F. Okada , Y. Asayama , M. Ogata , K. Takano , E. Ohtsuka

{"title":"Centrilobular nodules are predictive chest computed tomography (CT) findings related to adult T-cell leukemia/lymphoma development in human T-lymphotropic virus type I carriers","authors":"H. Sato , F. Okada , Y. Asayama , M. Ogata , K. Takano , E. Ohtsuka","doi":"10.1016/j.crad.2024.106765","DOIUrl":"10.1016/j.crad.2024.106765","url":null,"abstract":"<div><h3>Aim</h3><div>To evaluate predictive chest computed tomography (CT) findings associated with the development of adult T-cell leukemia/lymphoma (ATLL) in human T-lymphotropic virus type I (HTLV-1) carriers.</div></div><div><h3>Materials and methods</h3><div>This retrospective study examined 171 adult T-cell leukemia/lymphoma and 158 HTLV-1 carriers who were treated from November 2004 to April 2021. The radiological features of 888 chest CT scans in total were retrospectively assessed by two chest radiologists who were unaware of the underlying diagnoses and compared between the groups.</div></div><div><h3>Results</h3><div>In patients with aggressive type ATLL (acute type and lymphoma type), lymph node enlargement was the most frequently observed abnormality (65.2%), followed by ground-glass opacity (33.3%) and pleural effusion (30.4%). In patients with indolent type (chronic type and smoldering type), lymph node enlargement, and bronchiectasis were the most frequently observed abnormalities (5.6% and 5.6%, respectively). In each type, centrilobular nodules were observed in none and in one patient, respectively. In the 158 HTLV-1 carriers, centrilobular nodules (<em>n</em> = 62; 39.2%) were the most frequently observed abnormality. Centrilobular nodules were significantly frequently observed in HTLV-1 carriers compared with ATLL patients. No HTLV-1 carrier with centrilobular nodules on CT developed ATLL during the duration of care. A comparative analysis between CT scans performed before ATLL development in ATLL patients and those of HTLV-1 carriers showed that no centrilobular nodules were observed on the pre-ATLL CT scans, and a statistically-significant difference in centrilobular nodules was found between these two groups.</div></div><div><h3>Conclusion</h3><div>The presence of centrilobular nodules may be an indicative CT finding in HTLV-1 carriers who are less likely to develop ATLL.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"81 ","pages":"Article 106765"},"PeriodicalIF":2.1,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142902609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Paid MBP advert Last chance to book_AI-Conference-A4-NHS_Final_02

IF 2.1 3区医学

Clinical radiology Pub Date : 2025-02-01 DOI: 10.1016/S0009-9260(25)00039-X

引用次数: 0